Bank of New York Mellon Corp

Bank

Position in CADL — Candel Therapeutics, Inc.

CIK 1390777 NEW YORK, NY

Position in CADL

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$667,702

+$129,778 QoQ

Shares Held

136,266

+43.1% QoQ

Ownership

0.186%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 98.26002084158925.ToString("F0")% Shared 0.ToString("F0")% None 1.7399791584107556.ToString("F0")%

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. CADL ranks #196 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,586,427	$708,403,098
2	REGN	Regeneron Pharmaceuticals, Inc.	765,411	$591,387,145
3	JAZZ	Jazz Pharmaceuticals plc	1,679,371	$317,485,079
4	INSM	INSMED Inc	1,262,749	$206,484,708
5	ALNY	Alnylam Pharmaceuticals, Inc.	491,200	$162,523,337
6	INCY	Incyte Corp	989,709	$93,151,403
7	TECH	BIO-TECHNE Corp	1,759,119	$91,931,549
8	MRNA	Moderna, Inc.	1,691,205	$85,913,207

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$667,702	136,266	+43.1%	Shares	Defined	2026-05-05
2025-12-31	$537,924	95,208	+0.7%	Shares	Defined	2026-02-10
2025-09-30	$482,300	94,569	+8.9%	Shares	Defined	2025-11-03
2025-06-30	$439,226	86,804	+42.9%	Shares	Defined	2025-08-05
2025-03-31	$343,287	60,759	+35.1%	Shares	Defined	2025-04-29
2024-12-31	$390,426	44,980	+0.0%	Shares	Defined	2025-02-04
2024-09-30	$311,695	44,978	-17.4%	Shares	Defined	2024-11-12
2024-06-30	$337,582	54,449	—	Shares	Defined	2024-07-25
No filing history on record for this holder in this stock.